SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PAPI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 54.840
AS - Asia 25.798
EU - Europa 14.757
SA - Sud America 4.423
Continente sconosciuto - Info sul continente non disponibili 1.390
AF - Africa 647
OC - Oceania 201
Totale 102.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 53.288
SG - Singapore 9.277
CN - Cina 5.368
IT - Italia 4.197
BR - Brasile 3.349
VN - Vietnam 2.717
HK - Hong Kong 2.419
DE - Germania 1.907
UA - Ucraina 1.892
BD - Bangladesh 1.607
GB - Regno Unito 1.392
FI - Finlandia 1.325
TR - Turchia 1.187
FR - Francia 869
NL - Olanda 773
JP - Giappone 749
CA - Canada 746
RU - Federazione Russa 646
SE - Svezia 579
IN - India 575
ID - Indonesia 546
MX - Messico 420
AR - Argentina 383
PL - Polonia 319
IQ - Iraq 197
ZA - Sudafrica 185
AU - Australia 179
EC - Ecuador 166
ES - Italia 165
PK - Pakistan 162
CO - Colombia 153
AT - Austria 123
PH - Filippine 122
MY - Malesia 106
VE - Venezuela 102
SA - Arabia Saudita 96
MA - Marocco 94
PY - Paraguay 84
KR - Corea 83
BE - Belgio 79
UZ - Uzbekistan 76
JM - Giamaica 75
EG - Egitto 72
LT - Lituania 72
AE - Emirati Arabi Uniti 69
CL - Cile 69
TW - Taiwan 68
TN - Tunisia 67
KE - Kenya 65
CR - Costa Rica 60
PE - Perù 54
CZ - Repubblica Ceca 53
TH - Thailandia 45
IE - Irlanda 44
CH - Svizzera 42
DZ - Algeria 41
GT - Guatemala 38
HN - Honduras 35
JO - Giordania 33
UY - Uruguay 33
NP - Nepal 32
PT - Portogallo 32
KZ - Kazakistan 31
LB - Libano 28
IL - Israele 27
RO - Romania 27
AL - Albania 26
AZ - Azerbaigian 24
GR - Grecia 24
NI - Nicaragua 24
TT - Trinidad e Tobago 24
BO - Bolivia 23
SV - El Salvador 23
IR - Iran 21
EE - Estonia 20
NZ - Nuova Zelanda 20
ET - Etiopia 19
HR - Croazia 18
PR - Porto Rico 18
PS - Palestinian Territory 18
RS - Serbia 18
BG - Bulgaria 17
DO - Repubblica Dominicana 17
BB - Barbados 15
MK - Macedonia 15
PA - Panama 14
EU - Europa 13
GE - Georgia 13
HU - Ungheria 13
NG - Nigeria 12
BH - Bahrain 11
OM - Oman 11
SY - Repubblica araba siriana 11
DK - Danimarca 10
SN - Senegal 10
VI - Stati Uniti Isole Vergini 10
MD - Moldavia 9
SI - Slovenia 9
XK - ???statistics.table.value.countryCode.XK??? 9
BY - Bielorussia 8
Totale 100.461
Salva come PNG Salva come JPEG
Città #
Ashburn 6.384
Singapore 5.675
Fairfield 4.050
Woodbridge 3.632
San Jose 3.239
Houston 2.688
Hong Kong 2.371
Jacksonville 2.063
Council Bluffs 2.050
Santa Clara 2.017
Dallas 1.738
Chandler 1.631
Seattle 1.603
Wilmington 1.439
Beijing 1.399
Ann Arbor 1.327
Cambridge 1.320
Los Angeles 1.083
New York 1.055
Ho Chi Minh City 897
Helsinki 732
Izmir 702
Tokyo 701
Milan 655
Nanjing 639
Hanoi 634
Princeton 567
Lauterbourg 549
Munich 520
San Diego 385
Jakarta 375
Chicago 355
Ferrara 349
Boardman 319
Rome 298
São Paulo 287
Washington 286
Warsaw 282
Mexico City 257
Buffalo 253
Toronto 246
Orem 239
San Francisco 225
Phoenix 222
Shanghai 219
Denver 216
London 215
Atlanta 208
Nanchang 197
Montreal 187
Tianjin 178
Shenyang 173
Brooklyn 155
Hefei 155
Frankfurt am Main 145
Moscow 143
Naples 134
Addison 131
Da Nang 130
Hebei 124
Boston 117
Changsha 116
Lappeenranta 116
Nuremberg 114
Dearborn 112
Bologna 109
Rio de Janeiro 104
Haiphong 103
Jiaxing 102
Turku 93
Chennai 92
Dong Ket 90
Mountain View 87
Stockholm 86
The Dalles 85
Guangzhou 84
Falls Church 80
Baghdad 78
Falkenstein 76
Redwood City 74
Norwalk 72
Zhengzhou 70
Brasília 67
Columbus 67
Belo Horizonte 66
Manchester 66
Tashkent 66
Johannesburg 65
Miami 65
Turin 65
Amsterdam 64
Figino 64
Curitiba 62
Mumbai 62
Quito 61
Sydney 61
Vienna 61
Philadelphia 59
Kuala Lumpur 58
Dhaka 57
Totale 63.644
Salva come PNG Salva come JPEG
Nome #
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 1.455
Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study 1.364
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review 866
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 688
Air pollution and COPD: GOLD 2023 committee report 619
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 557
Asthma 533
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 497
From Gold 0 to Pre-COPD 465
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 461
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 415
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 356
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 356
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 355
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 340
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 333
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A GOLD Science Committee 2022 Review 319
Targeting Th2 cells in asthmatic airways 312
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 306
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 304
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 301
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary 300
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 295
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 293
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 287
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 284
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 283
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 270
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 269
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 266
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 265
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 261
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 259
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 255
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 254
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 251
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 251
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 249
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 245
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 242
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 238
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 237
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 236
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 235
A serum proteome signature to predict mortality in severe COVID-19 patients 234
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 233
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 233
Respiratory Syncytial Virus Infection in Older Adults: An Update 233
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 232
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 232
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 231
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 231
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 230
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 229
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 228
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 228
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 228
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 228
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 227
Asthma management 225
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 225
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 224
Malattie polmonari primitive da cause dismetaboliche. 224
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 224
Activation of NF-kappaB transcription factor in asthma death 223
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 223
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 223
Cellule staminali e patologia polmonare dell’adulto 222
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 221
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 220
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 219
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 218
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 216
A defective type 1 response to rhinovirus in atopic asthma 215
COPD exacerbations: definitions and classifications 214
COPD: early diagnosis and treatment to slow disease progression 214
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 214
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 213
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 213
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 212
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 212
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 211
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 210
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 210
Enfisema polmonare: prospettive di terapia 209
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 209
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 209
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 209
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 207
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 206
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 206
Apporto esogeno di riducenti e attività del rinovirus HRV16 205
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 205
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 205
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 204
Rhinovirus vaccination: the case against 203
Achieving the balance between evidence and simplicity 203
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma 203
Models of infection and exacerbations in COPD. 202
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 202
Totale 29.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 455.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 20.307
Totale 476.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.155 0 0 0 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202638.479 2.708 1.677 3.921 4.392 4.676 2.199 4.067 2.238 3.792 4.235 2.590 1.984
2026/202713.499 3.029 4.406 4.555 1.509 0 0 0 0 0 0 0 0
Totale 102.056